Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
LexaGene financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2023-04-25
Market Capitalization
$11.3 M
2023-04-25
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | Q2, 2023 | Q3, 2023 |
|---|---|---|
| Revenue | 60.8K | 42.9K |
| Cost of goods sold | 247.4K | 189.9K |
| Gross profit | (186.6K) | (147.0K) |
| Gross profit margin, % | -306.7% | -342.6% |
| General and administrative expense | 575.9K | 471.0K |
| Operating expense total | 1.9M | 1.5M |
| EBIT | (2.1M) | (1.7M) |
| EBIT margin, % | -3414.2% | -3897.9% |
| Pre tax profit | (2.1M) | |
| Net Income | (2.1M) | (1.7M) |
| EPS | 0.0 | 0.0 |